What does Ocular Therapeutix, Inc. do?
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to…
What is Ocular Therapeutix, Inc.'s P/E and P/B ratio?
Ocular Therapeutix, Inc. has a P/E ratio of -4.7 and a P/B ratio of 2.79.
What is Ocular Therapeutix, Inc.'s debt-to-equity ratio?
Ocular Therapeutix, Inc. has a debt-to-equity ratio of 0.15.
How much does Ocular Therapeutix, Inc. owe compared with what it owns?
Ocular Therapeutix, Inc. owes $0.23 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Ocular Therapeutix, Inc.'s Positivity rank?
Ocular Therapeutix, Inc. is ranked #3,549 of 6,774 companies globally and #1,550 of 4,000 in United States on PositoAI, with a Positivity Score of 20,473.
Does Ocular Therapeutix, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Ocular Therapeutix, Inc..
Where can I read the latest news about Ocular Therapeutix, Inc.?
Recent headlines about Ocular Therapeutix, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Ocular Therapeutix, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Ocular Therapeutix, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.